HK50580A - 4'-alkoxyalkyleneoxy-5-benzylpyrimidines, their preparation and pharmaceutical compositions thereof - Google Patents

4'-alkoxyalkyleneoxy-5-benzylpyrimidines, their preparation and pharmaceutical compositions thereof

Info

Publication number
HK50580A
HK50580A HK505/80A HK50580A HK50580A HK 50580 A HK50580 A HK 50580A HK 505/80 A HK505/80 A HK 505/80A HK 50580 A HK50580 A HK 50580A HK 50580 A HK50580 A HK 50580A
Authority
HK
Hong Kong
Prior art keywords
alkoxyalkyleneoxy
benzylpyrimidines
preparation
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
HK505/80A
Other languages
English (en)
Original Assignee
Heumann Ludwig & Co Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19732313361 external-priority patent/DE2313361C3/de
Application filed by Heumann Ludwig & Co Gmbh filed Critical Heumann Ludwig & Co Gmbh
Publication of HK50580A publication Critical patent/HK50580A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HK505/80A 1973-03-17 1980-09-04 4'-alkoxyalkyleneoxy-5-benzylpyrimidines, their preparation and pharmaceutical compositions thereof HK50580A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732313361 DE2313361C3 (de) 1973-03-17 2,4-Diamino-5-(3',5'-dimethoxy-4'-methoxyalkoxybenzyl-pyrimidine

Publications (1)

Publication Number Publication Date
HK50580A true HK50580A (en) 1980-09-12

Family

ID=5875077

Family Applications (1)

Application Number Title Priority Date Filing Date
HK505/80A HK50580A (en) 1973-03-17 1980-09-04 4'-alkoxyalkyleneoxy-5-benzylpyrimidines, their preparation and pharmaceutical compositions thereof

Country Status (16)

Country Link
US (1) US3992379A (de)
JP (1) JPS584025B2 (de)
AR (1) AR207561A1 (de)
AT (1) AT338795B (de)
AU (1) AU476979B2 (de)
BE (1) BE812375A (de)
BR (1) BR7401966D0 (de)
CA (1) CA1063607A (de)
CH (1) CH601257A5 (de)
ES (1) ES424274A1 (de)
FR (1) FR2221147B1 (de)
GB (1) GB1413454A (de)
HK (1) HK50580A (de)
HU (1) HU166864B (de)
IT (1) IT1060117B (de)
NL (1) NL175414C (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115650A (en) * 1976-11-17 1978-09-19 Hoffmann-La Roche Inc. Process for preparing 2,4-diamino-5-(substituted benzyl)-pyrimidines
US4103902A (en) * 1977-08-16 1978-08-01 Foster Wheeler Energy Corporation Water seal for regenerator
US4258045A (en) * 1979-11-30 1981-03-24 Merck & Co., Inc. Inhibitor of dihydrofolate reductase
EP0054756B1 (de) * 1980-11-27 1986-07-23 The Wellcome Foundation Limited Antibakterielle Benzylpyrimidine
JPS60107889U (ja) * 1983-12-20 1985-07-22 トキコ株式会社 給油量表示装置
DE3613794A1 (de) * 1986-04-24 1987-10-29 Frank Joachim Mueller Verfahren zum nachweis von antibiotika- und sulfonamidrueckstaenden in biologischen fluessigkeiten oder nahrungsmitteln

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909522A (en) * 1957-02-21 1959-10-20 Burroughs Wellcome Co Trialkoxybenzylpyrimidines and method
GB1142654A (en) * 1965-10-28 1969-02-12 Wellcome Found Cyano-acetals and their use in benzylpyrimidine synthesis
GB1229413A (de) * 1967-06-14 1971-04-21
US3849407A (en) * 1969-03-06 1974-11-19 Burroughs Wellcome Co 5-benzyl pyrimidines intermediates
US3819629A (en) * 1970-02-10 1974-06-25 Burroughs Wellcome Co Method for preparing 2,4-diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine
US3692787A (en) * 1970-02-16 1972-09-19 Burroughs Wellcome Co Substituted 2,4-diamino-5-benzyl pyrimidines
US3772289A (en) * 1970-10-22 1973-11-13 Burroughs Wellcome Co Alkyl substituted benzyl pyrimidines

Also Published As

Publication number Publication date
IT1060117B (it) 1982-07-10
FR2221147B1 (de) 1982-06-11
NL7403411A (de) 1974-09-19
JPS584025B2 (ja) 1983-01-24
JPS5035176A (de) 1975-04-03
US3992379A (en) 1976-11-16
AT338795B (de) 1977-09-12
ES424274A1 (es) 1976-11-01
DE2313361A1 (de) 1975-02-06
BE812375A (fr) 1974-07-01
BR7401966D0 (pt) 1974-11-05
NL175414C (nl) 1984-11-01
DE2313361B2 (de) 1975-07-10
FR2221147A1 (de) 1974-10-11
CA1063607A (en) 1979-10-02
CH601257A5 (de) 1978-06-30
AR207561A1 (es) 1976-10-15
NL175414B (nl) 1984-06-01
AU476979B2 (en) 1976-10-07
AU6671374A (en) 1975-09-18
GB1413454A (en) 1975-11-12
HU166864B (de) 1975-06-28
ATA215474A (de) 1977-01-15

Similar Documents

Publication Publication Date Title
IL43872A (en) 2-amino-5-alkyl-imidazo-(5,1-f)-as-triazine derivatives, their preparation and pharmaceutical compositions containing them
IL44338A0 (en) New s-triazolo-(4,3-a)benzodiazepines-1,5,their preparation and pharmaceutical compositions containing them
IL43762A0 (en) Novel 11,11-alkylidene-steroids,their preparation and pharmaceutical compositions containing them
IL43955A0 (en) Novel 1,4-benzodioxane derivatives,their preparation and pharmaceutical compositions containing them
IL46050A0 (en) Azepinoquinoline derivatives,their preparation and pharmaceutical compositions containing them
IL46966A0 (en) 1,1-diaryl-1-oxadiazolyl-alkylamines,their preparation and pharmaceutical compositions containing them
IL45516A (en) 3,20-dioxo-17aalpha-hydroxy-d-homopregn-4-enes their manufacture and pharmaceutical compositions containing them
IL49424A0 (en) 1,1,1-triaryl-alkylamines,their preparation and pharmaceutical compositions containing them
IL44873A0 (en) New pyrazolo-s-triazine derivatives,their preparation and pharmaceutical compositions containing them
IL46183A (en) 3-aminoalkylamino-1-phenoxy-2propanol derivatives,their preparation and pharmaceutical compositions comprising them
NZ178810A (en) 2,6-disubstituted 2-phenylimino-imidazolidines, preparation and pharmaceutical compositions
IL44222A0 (en) New diphenylpropylamines,their preparation and pharmaceutical compositions containing them
IL49132A (en) 16,1l-disubstituted androst-4-en-3-ones,their preparation and pharmaceutical compositions containing them
KE2740A (en) 2,3-dihydrobenzofuranyl-7-n-methyl-carbamates, their preparation and their use as insecticides
IL44266A0 (en) Novel substituted 2-phenylamino-imidazolines-(2) and their salts,their preparation and pharmaceutical compositions containing them
HK50580A (en) 4'-alkoxyalkyleneoxy-5-benzylpyrimidines, their preparation and pharmaceutical compositions thereof
IL44895A0 (en) New thiazoloisoquinolines,their preparation and pharmaceutical compositions containing them
IL45995A0 (en) New substituted thiazole-2-carboxamides,their preparation and pharmaceutical compositions containing them
IL44267A (en) Glycopeptides, their preparation and pharmaceutical compositions containing them
IL44418A0 (en) Novel benzodiazepines,their preparation and pharmaceutical compositions containing them
IL44849A0 (en) New nitrocarbostyrils,their preparation and pharmaceutical compositions containing them
IL46116A0 (en) Novel alkenesulfonamides,their preparation and pharmaceutical compositions containing them
IL46409A (en) 7,8-dihalo-1,2,3,4-tetrahydro-isoquinolines their preparation and pharmaceutical compositions containing them
IL50554A (en) 2,9-dioxatricyclodecanes,their preparation and pharmaceutical compositions containing them
IL45970A0 (en) New thiazolylurea derivatives,their preparation and pharmaceutical compositions containing them